Puretech Health revenues slide, losses widen
9th Apr 2020 09:09
(Sharecast News) - Clinical-stage biotherapeutics company Puretech Health posted weaker full-year revenues and a widened operating loss on Thursday and also noted it was yet to see any impact to ongoing work as a result of the Covid-19 outbreak.
Read morePureTech begins next study of lymphoedema drug candidate
3rd Mar 2020 08:04
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health announced on Tuesday that the first participant has been dosed in a clinical study of 'LYT-100', its wholly-owned product candidate for the potential treatment of lymphoedema and other fibrotic conditions.
Read moreFriday broker round-up
24th Jan 2020 12:45
(Sharecast News) - TT Electronics: Jefferies downgrades to hold with a target price of 265p.
Read morePureTech sells shares in Karuna affiliate for $200m
23rd Jan 2020 07:44
(Sharecast News) - Clinical stage biotech company PureTech Health said it had sold 2.1m shares of its affiliate Karuna Therapeutics for $200m.
Read morePureTech affiliate Follica reports 44% improvement in hair-loss study
19th Dec 2019 08:25
(Sharecast News) - PureTech Health on Thursday said results from a study into a hair loss treatment developed by its affiliate Follica demonstrated a statistically significant 44% improvement in hair count.
Read morePureTech affiliate Gelesis secures $84.6m in new capital
9th Dec 2019 09:37
(Sharecast News) - Biotechnology commercialisation company PureTech Health noted on Monday that its affiliate Gelesis had secured $84.6m (£64.26m) in new capital.
Read morePureTech Health affiliate Vedanta Biosciences awarded $5.8m grant
5th Dec 2019 08:14
(Sharecast News) - Clinical stage biotechnology company PureTech Health said on Thursday that its affiliate, Vedanta Biosciences, has been awarded a $5.8m grant for its 'VE707' programme, targeting multidrug resistant infections.
Read moreWednesday broker round-up
20th Nov 2019 13:27
(Sharecast News) - Burford Capital: Berenberg downgrades to hold with a target price of 810p.
Read morePureTech Health surges on positive Karuna Therapeutics drug trial
19th Nov 2019 12:20
(Sharecast News) - PureTech Health surged on Tuesday after US biopharmaceutical company Karuna Therapeutics - in which it owns a 32% stake - said a day earlier that a phase 2 trial of its schizophrenia treatment met its primary endpoint.
Read morePureTech affiliate Sonde Health names David Liu as CEO
24th Oct 2019 08:09
(Sharecast News) - Clinical stage biotechnology company PureTech Health announced on Thursday that its affiliate Sonde Health had appointed David Liu as chief executive officer and a member of its board of directors.
Read moreFTSE 250 movers: PureTech falls, Mediclinic climbs
16th Oct 2019 13:42
(Sharecast News) - London's FTSE 250 was 0.31% lower at 19,134.998 in afternoon trade on Wednesday, as PureTech Health led the index lower.
Read morePureTech secures remaining 10% of Ariya Therapeutics
2nd Oct 2019 08:12
(Sharecast News) - PureTech Health on Wednesday acquired the remaining 10% of Ariya Therapeutics, with the now wholly-owned subsidiary set to be renamed as PureTech LYT.
Read morePureTech narrows losses in 'most ambitious year yet'
24th Apr 2019 09:17
(Sharecast News) - Biopharmaceutical company PureTech Health grew revenues and narrowed losses in its "most ambitious year yet".
Read morePureTech Health investment Vor Biopharma raises $42m in funding round
14th Feb 2019 12:28
(Sharecast News) - Advanced biopharmaceutical company PureTech Health noted on Thursday that its affiliate, Vor Biopharma, had raised $42m in a Series A financing round.
Read morePeel Hunt picks 'doublers' for the next 2-3 years
18th Dec 2018 11:09
(Sharecast News) - Peel Hunt has named 29 companies it believes will double in value in the next two to three years, including JD Sports, GoCompare and CMC Markets.
Read more